Journal of Nanomedicine and Nanotechnology celebrates more than a decade of its existence in the field of nano publishing and research and extends a very warm welcome to all the authors, researchers, editors and student to contribute their latest research findings as full length articles to this collaborative medical journal. The journal is committed to serve its readers authors by adding the state of the art facilities to enhance the author’s scholarly visibility.
Established in the year 2010, Journal of Nanomedicine and Nanotechnology is one of the most reputed journals of LONGDOM group, the collaborative medical publisher, known for its close-knit association with medical societies and agencies engaged in medical research. The journal has been publishing the most recent developments in the fields of Nanomedicine, Nanotechnology, Radiological, Drug delivery as full length research articles and case studies.
Notwithstanding to any specific organ in the body, the journal has so far published voluminous issues on Nanotechnology: Challenges and Perspectives in Medicine.
With a PhD from Université de Montréal in 1996 and after completing postdoctoral fellowships at McGill University and the University of Toronto (1996-1998), Dr. Abdelwahab Omri spent more than 2 years as Research associate at NRC (institute of biological sciences in Ottawa) from 1998 to 2000. Dr Omri is currently Full Professor in the Department of Chemistry and Biochemistry with a cross appointment to the Department of Biology, the Biomolecular Sciences PhD Programme, School of Rural and Northern Health PhD Programme. Dr. Omri’s research interests are focused on Lipid-based drug and vaccine delivery systems. His laboratory employs a multi-disciplinary approach to addressing the antimicrobial resistance to gram negative bacteria in cystic fibrosis patients and in medical devices implants. Dr. Omri is also involved in the education of undergraduate and graduate students through the coordination of several calendar courses in biochemistry, pharmacology and toxicology and pharmaceutical technology. In addition to research, Dr. Omri is actively involved in the research training of both undergraduate and graduate students. Dr. Omri has served in administrative capacities in several international scientific societies. He has published over 50 peer-reviewed research articles over his career on various aspects of drug delivery and targeting in addition to several published book chapters and books. He has served on a number of Editorial Boards and Granting Agencies in Canada and abroad. Dr. Omri has 2 patents.
Listed and indexed in the reputed indexing sites like EBSCO, Geneva Foundation for Medical Education and Research Publons, the Journal of Nanomedicine and Nanotechnology is committed to ‘Creative Commons’ policy of publishing the scholarly articles on open access forum, after a thorough peer review. The journal is enjoying the staunch support of LONGDOM, a faithful publisher committed to medical science research.
The LONGDOM Group has become an ultimate destination to the world-class, peer-review medical journals till date. LONGDOM medical publications are highly respected by physicians, surgeons, practitioners, and researchers alike and thus become an essential part of the international medical landscape for publishing scientific literature, which is critical to the research cycle.
On the eve completing more than a decade in medical publishing, the Journal of Nanomedicine and Nanotechnology waives off 50% of its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Nano Research.
Journal of Nanomedicine and Nanotechnology
Longdom Publishing SL, C/ Sant Gil 3, 2-3,
08001 Barcelona, Spain
Tel: +34 911 877 608